• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

城市社区中的慢性疼痛性周围神经病变:糖尿病患者与非糖尿病患者的对照比较

Chronic painful peripheral neuropathy in an urban community: a controlled comparison of people with and without diabetes.

作者信息

Daousi C, MacFarlane I A, Woodward A, Nurmikko T J, Bundred P E, Benbow S J

机构信息

Diabetes and Endocrinology Research Group, University Hospital Aintree, Liverpool, UK.

出版信息

Diabet Med. 2004 Sep;21(9):976-82. doi: 10.1111/j.1464-5491.2004.01271.x.

DOI:10.1111/j.1464-5491.2004.01271.x
PMID:15317601
Abstract

AIMS

A cross-sectional study has been performed in order to estimate the prevalence, severity, and current treatment of chronic painful peripheral neuropathy (CPPN) in people with diabetes in the community.

METHODS

Using a structured questionnaire and examination we have assessed these factors in a community sample of people with diabetes (n=350) and compared them with 344 age- and sex-matched people without diabetes from the same locality.

RESULTS

The prevalence of CPPN was estimated to be 16.2%[95% confidence interval (CI): 6.8-16%] in people with diabetes compared with 4.9% (95% CI: 2.6-7.2%) in the control sample (P < 0.0001). Diabetic subjects with and without CPPN did not differ in age, sex, type and duration of diabetes, body mass index, smoking status and glycaemic control. However, CPPN diabetic subjects had significantly higher Visual Analogue Scale (VAS) scores for pain over the preceding 24 h [median (interquartile range) 3.5 (1.5-6.7) cm vs. 0.7 (0-3.9) cm, P < 0.0001]. Also, the total McGill Pain Questionnaire Score (a measure of pain quality and severity) was 18 (13-31.5) vs. 10 (4-16) (P < 0.0001). Of patients with diabetes and CPPN, 12.5% (7/56) had never reported their symptoms to their treating physician and 39.3% (22/56) had never received any treatment for their painful symptoms.

CONCLUSIONS

CPPN is common, often severe but frequently unreported and inadequately treated.

摘要

目的

开展一项横断面研究,以评估社区糖尿病患者中慢性疼痛性周围神经病变(CPPN)的患病率、严重程度及当前治疗情况。

方法

我们使用结构化问卷和检查,对社区中350名糖尿病患者样本的这些因素进行了评估,并将其与来自同一地区的344名年龄和性别匹配的非糖尿病患者进行比较。

结果

糖尿病患者中CPPN的患病率估计为16.2%[95%置信区间(CI):6.8 - 16%],而对照样本中的患病率为4.9%(95%CI:2.6 - 7.2%)(P < 0.0001)。有和没有CPPN的糖尿病患者在年龄、性别、糖尿病类型和病程、体重指数、吸烟状况及血糖控制方面无差异。然而,患有CPPN的糖尿病患者在前24小时的视觉模拟评分(VAS)疼痛得分显著更高[中位数(四分位间距)3.5(1.5 - 6.7)厘米对0.7(0 - 3.9)厘米,P < 0.0001]。此外,麦吉尔疼痛问卷总评分(一种衡量疼痛性质和严重程度的指标)为18(13 - 31.5)对10(4 - 16)(P < 0.0001)。在患有糖尿病和CPPN的患者中,12.5%(7/56)从未向其治疗医生报告过症状,39.3%(22/56)从未因疼痛症状接受过任何治疗。

结论

CPPN很常见,通常较为严重,但常常未被报告且治疗不足。

相似文献

1
Chronic painful peripheral neuropathy in an urban community: a controlled comparison of people with and without diabetes.城市社区中的慢性疼痛性周围神经病变:糖尿病患者与非糖尿病患者的对照比较
Diabet Med. 2004 Sep;21(9):976-82. doi: 10.1111/j.1464-5491.2004.01271.x.
2
The natural history of chronic painful peripheral neuropathy in a community diabetes population.社区糖尿病患者慢性疼痛性周围神经病变的自然病史。
Diabet Med. 2006 Sep;23(9):1021-4. doi: 10.1111/j.1464-5491.2006.01904.x.
3
Prevalence of painful diabetic peripheral neuropathy among patients suffering from diabetes mellitus in Saudi Arabia.沙特阿拉伯糖尿病患者中疼痛性糖尿病周围神经病变的患病率。
Curr Med Res Opin. 2010 Feb;26(2):337-43. doi: 10.1185/03007990903471940.
4
The effect of venlafaxine HCl on painful peripheral diabetic neuropathy in patients with type 2 diabetes mellitus.盐酸文拉法辛对2型糖尿病患者疼痛性周围神经病变的影响。
J Diabetes Complications. 2008 Jul-Aug;22(4):241-5. doi: 10.1016/j.jdiacomp.2007.03.010. Epub 2008 Apr 16.
5
Painful diabetic neuropathy: a cross-sectional survey of health state impairment and treatment patterns.疼痛性糖尿病神经病变:健康状态损害及治疗模式的横断面调查
J Diabetes Complications. 2006 Jan-Feb;20(1):26-33. doi: 10.1016/j.jdiacomp.2005.09.007.
6
The prevalence, severity, and impact of painful diabetic peripheral neuropathy in type 2 diabetes.2型糖尿病中疼痛性糖尿病周围神经病变的患病率、严重程度及影响
Diabetes Care. 2006 Jul;29(7):1518-22. doi: 10.2337/dc05-2228.
7
Peripheral neuropathy in type 2 diabetes mellitus in Isfahan, Iran: prevalence and risk factors.伊朗伊斯法罕2型糖尿病患者的周围神经病变:患病率及危险因素
Acta Neurol Scand. 2006 Dec;114(6):384-91. doi: 10.1111/j.1600-0404.2006.00716.x.
8
Sleep impairment in patients with painful diabetic peripheral neuropathy.疼痛性糖尿病周围神经病变患者的睡眠障碍
Clin J Pain. 2006 Oct;22(8):681-5. doi: 10.1097/01.ajp.0000210910.49923.09.
9
The prevalence of diabetic peripheral neuropathy in an outpatient setting.门诊环境中糖尿病周围神经病变的患病率。
Med J Malaysia. 2003 Oct;58(4):533-8.
10
Prevalence, interference, and risk factors for chronic pain among Taiwanese community older people.台湾社区老年人慢性疼痛的患病率、干扰因素及风险因素
Pain Manag Nurs. 2006 Mar;7(1):2-11. doi: 10.1016/j.pmn.2005.12.002.

引用本文的文献

1
EEG neurofeedback for the treatment of neuropathic pain in the elderly-a mechanistic review.脑电图神经反馈治疗老年人神经性疼痛——一项机制综述
Geroscience. 2025 Aug 30. doi: 10.1007/s11357-025-01848-7.
2
Intravenous Streptozotocin Induces Variants in Painful Diabetic Peripheral Neuropathy in Female Mice.静脉注射链脲佐菌素可诱导雌性小鼠疼痛性糖尿病周围神经病变产生变异。
J Pain Res. 2025 Jul 2;18:3345-3357. doi: 10.2147/JPR.S523693. eCollection 2025.
3
Prevalence and risk factors for painful diabetic peripheral neuropathy: a systematic review and meta-analysis.
疼痛性糖尿病周围神经病变的患病率及危险因素:一项系统评价和荟萃分析。
Front Neurol. 2025 May 13;16:1564867. doi: 10.3389/fneur.2025.1564867. eCollection 2025.
4
Intravenous streptozotocin induces variants in painful diabetic peripheral neuropathy in female mice.静脉注射链脲佐菌素可诱导雌性小鼠疼痛性糖尿病周围神经病变出现变异。
Res Sq. 2025 Feb 21:rs.3.rs-6058617. doi: 10.21203/rs.3.rs-6058617/v1.
5
Promise of the gut microbiota in prevention and traditional Chinese medicine treatment of diabetic peripheral neuropathy.肠道微生物群在糖尿病周围神经病变预防及中医治疗中的前景
World J Diabetes. 2024 Dec 15;15(12):2387-2393. doi: 10.4239/wjd.v15.i12.2387.
6
Mapping the Journey of Patients with Painful Diabetic Peripheral Neuropathy in the Philippines.描绘菲律宾疼痛性糖尿病周围神经病变患者的历程
Acta Med Philipp. 2023 Jun 28;57(6):46-51. doi: 10.47895/amp.vi0.4471. eCollection 2023.
7
Current Perspectives in Pre- and Diabetic Peripheral Neuropathy Diagnosis and Management: An Expert Statement for the Gulf Region.糖尿病前期和糖尿病性周围神经病变诊断与管理的当前观点:海湾地区专家声明
Diabetes Ther. 2024 Dec;15(12):2455-2474. doi: 10.1007/s13300-024-01658-8. Epub 2024 Oct 26.
8
A Systematic Guideline by the ASPN Workgroup on the Evidence, Education, and Treatment Algorithm for Painful Diabetic Neuropathy: SWEET.糖尿病性周围神经病变疼痛的证据、教育与治疗算法的ASPN工作组系统性指南:SWEET。
J Pain Res. 2024 Apr 13;17:1461-1501. doi: 10.2147/JPR.S451006. eCollection 2024.
9
Neuropathic Pain With and Without Diabetic Peripheral Neuropathy in Type 1 Diabetes.1 型糖尿病伴或不伴糖尿病周围神经病变的神经病理性疼痛。
Diabetes Care. 2024 Sep 1;47(9):1559-1567. doi: 10.2337/dc23-1749.
10
Streptozotocin-Induced Diabetic Rats Showed a Differential Glycine Receptor Expression in the Spinal Cord: A GlyR Role in Diabetic Neuropathy.链脲佐菌素诱导的糖尿病大鼠脊髓甘氨酸受体表达差异:甘氨酸受体在糖尿病神经病变中的作用。
Neurochem Res. 2024 Mar;49(3):684-691. doi: 10.1007/s11064-023-04058-9. Epub 2023 Nov 29.